Romania – Medicinal products used in diabetes – Framework agreement for the supply of medicines for the National Diabetes Program

Opportunity description

Framework agreement for the supply of medicines for the National Diabetes Program. The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. Subsequent contracts will be concluded on the basis of the framework supply agreement, depending on the budgetary funds allocated for this purpose, the largest subsequent contract being estimated to be monthly or for any period covered by the available budget. The maximum estimated value of the largest subsequent contract, and the minimum and maximum total estimated value of the framework agreement for a period of 24 months are specified in the section Division into lots. EMPAGLIFLOZINUM 10 mg The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. METFORMINUM 1000 MG The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. TRESIBA – Insulin degludec solution for injection in pre-filled pen 100 UI/ml*3ml The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. FIASP –Fast-acting insulin aspart solution for injection in pre-filled pen 100 UI/ml*3ml The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. DULAGLUTID - Solution for injection in pre-filled pen *0.5 ml The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. DAPAGLIFLOZIN 10 MG The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. EMPAGLIFLOZIUNUM + METFORMINUM - 5 MG /1000 MG The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. DAPAGLIFLOZIUNUM + METFORMINUM - 5 MG /1000 MG The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. SEMAGLUTIDUM 1.5 MG The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. SEMAGLUTIDUM 4 MG The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. SEMAGLUTIDUM 9 MG The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. Semaglutidum 0.25 mg Box*1 pre-filled pen + 4 needles The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. Semaglutidum 0.5 mg Box* 3 pre-filled pens +12 needles The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. Semaglutidum 1 mg Box*3 pre-filled pens + 12 needles The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. VILDAGLIPTINUM 50 MG The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. VILDAGLIPTINUM + METFORMINUM 1000 MG / 50 MG The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. TOUJEO SOLOSTAR-Insulin glargine300UI/ml * 1.5 ml The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. XULTOPHY – Insulin degludec + Liraglutide 100UI /ml + 3.6mg/ ml Solution for injection in pen * 3 ml The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. HUMULIN R Kwikpen – Soluble human insulin 100UI/ ml in pre-filled pen * 3 ml The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. SITAGLIPTINUM 100 mg The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. SITAGLIPTINUM 50 mg The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. NOVOMIX 30 FLEXPEN – Insulinum aspart box*5 pre-filled injection pens *100ui /ml*3ml The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. HUMALOG KWIK PEN Insulinum lispro Box*5 pre-filled injection pens 100 ui/ ml-3 ml The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. SITAGLIPTINUM / METFORMINUM 50 mg/1000 mg The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. GLICLAZIDUM 60 MG The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. ABASAGLAR -Insulin glargine 100UI/ml*3 ml The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. EMPAGLIFLOZINUM 25 mg The minimum and maximum quantities of the framework agreement are specified in the Tender Specifications. Procedure: open. Estimated value: 1,496,936.7 RON. Review the original TED notice for the complete requirement, lots, amendments and attachments.